Jump to main content
博士論文

Development of UTX-121 and its derivatives as novel matrix metalloproteinase-2/9 inhibitors using celecoxib as a lead compound

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Development of UTX-121 and its derivatives as novel matrix metalloproteinase-2/9 inhibitors using celecoxib as a lead compound

Persistent ID (NDL)
info:ndljp/pid/12263336
Material type
博士論文
Author
山花, 啓梨
Publisher
-
Publication date
2022-03-01
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
徳島大学,博士(工学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

Matrix metalloproteinases (MMP)-2/9 are closely associated with cancer malignancy, and it has been considered that the inhibition of these MMPs may be...

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
山花, 啓梨
Author Heading
Publication Date
2022-03-01
Publication Date (W3CDTF)
2022-03-01
Alternative Title
Celecoxibをリードとした新規MMP-2/9阻害剤UTX-121およびその誘導体の開発
Degree grantor/type
徳島大学
Date Granted
2022-03-01
Date Granted (W3CDTF)
2022-03-01